The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Darbepoetin Alfa Market Research Report 2025
Synopsis
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
The global Darbepoetin Alfa market was valued at US$ 4904 million in 2023 and is anticipated to reach US$ 4010.1 million by 2030, witnessing a CAGR of -2.8% during the forecast period 2024-2030.
The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.
Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.
North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.
Market competition is not intense. Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Novartis and 3SBio etc. are the leaders of the industry, with about 87% market shares.
This report aims to provide a comprehensive presentation of the global market for Darbepoetin Alfa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Darbepoetin Alfa.
Report Scope
The Darbepoetin Alfa market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Darbepoetin Alfa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Darbepoetin Alfa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
Segment by Type
Epogen
Procrit
Aranesp
Others
Segment by Application
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Darbepoetin Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Darbepoetin Alfa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
The global Darbepoetin Alfa market was valued at US$ 4904 million in 2023 and is anticipated to reach US$ 4010.1 million by 2030, witnessing a CAGR of -2.8% during the forecast period 2024-2030.
The classification of Darbepoetin Alfa includes Epogen, Procrit, Aranesp and others, and the proportion of Epogen in 2017 is about 45%.
Darbepoetin Alfa is widely used for Patients with Chronic Kidney Disease, Patients with Cancer others. The most proportion of Darbepoetin Alfa is used for the Patients with Chronic Kidney Disease, and the proportion in 2017 is 62%.
North America is the largest consumption place, with a consumption market share nearly 47% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 41%.
Market competition is not intense. Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Novartis and 3SBio etc. are the leaders of the industry, with about 87% market shares.
This report aims to provide a comprehensive presentation of the global market for Darbepoetin Alfa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Darbepoetin Alfa.
Report Scope
The Darbepoetin Alfa market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Darbepoetin Alfa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Darbepoetin Alfa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
Segment by Type
Epogen
Procrit
Aranesp
Others
Segment by Application
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Darbepoetin Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Darbepoetin Alfa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Darbepoetin Alfa Market Overview
1.1 Product Overview and Scope of Darbepoetin Alfa
1.2 Darbepoetin Alfa Segment by Type
1.2.1 Global Darbepoetin Alfa Market Value Comparison by Type (2024-2030)
1.2.2 Epogen
1.2.3 Procrit
1.2.4 Aranesp
1.2.5 Others
1.3 Darbepoetin Alfa Segment by Application
1.3.1 Global Darbepoetin Alfa Market Value by Application: (2024-2030)
1.3.2 Patients with Chronic Kidney Disease
1.3.3 Patients with Cancer
1.3.4 Others
1.4 Global Darbepoetin Alfa Market Size Estimates and Forecasts
1.4.1 Global Darbepoetin Alfa Revenue 2019-2030
1.4.2 Global Darbepoetin Alfa Sales 2019-2030
1.4.3 Global Darbepoetin Alfa Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Darbepoetin Alfa Market Competition by Manufacturers
2.1 Global Darbepoetin Alfa Sales Market Share by Manufacturers (2019-2024)
2.2 Global Darbepoetin Alfa Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Darbepoetin Alfa Average Price by Manufacturers (2019-2024)
2.4 Global Darbepoetin Alfa Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Darbepoetin Alfa, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Darbepoetin Alfa, Product Type & Application
2.7 Darbepoetin Alfa Market Competitive Situation and Trends
2.7.1 Darbepoetin Alfa Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Darbepoetin Alfa Players Market Share by Revenue
2.7.3 Global Darbepoetin Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Darbepoetin Alfa Retrospective Market Scenario by Region
3.1 Global Darbepoetin Alfa Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Darbepoetin Alfa Global Darbepoetin Alfa Sales by Region: 2019-2030
3.2.1 Global Darbepoetin Alfa Sales by Region: 2019-2024
3.2.2 Global Darbepoetin Alfa Sales by Region: 2025-2030
3.3 Global Darbepoetin Alfa Global Darbepoetin Alfa Revenue by Region: 2019-2030
3.3.1 Global Darbepoetin Alfa Revenue by Region: 2019-2024
3.3.2 Global Darbepoetin Alfa Revenue by Region: 2025-2030
3.4 North America Darbepoetin Alfa Market Facts & Figures by Country
3.4.1 North America Darbepoetin Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Darbepoetin Alfa Sales by Country (2019-2030)
3.4.3 North America Darbepoetin Alfa Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Darbepoetin Alfa Market Facts & Figures by Country
3.5.1 Europe Darbepoetin Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Darbepoetin Alfa Sales by Country (2019-2030)
3.5.3 Europe Darbepoetin Alfa Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Darbepoetin Alfa Market Facts & Figures by Country
3.6.1 Asia Pacific Darbepoetin Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Darbepoetin Alfa Sales by Country (2019-2030)
3.6.3 Asia Pacific Darbepoetin Alfa Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Darbepoetin Alfa Market Facts & Figures by Country
3.7.1 Latin America Darbepoetin Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Darbepoetin Alfa Sales by Country (2019-2030)
3.7.3 Latin America Darbepoetin Alfa Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Darbepoetin Alfa Market Facts & Figures by Country
3.8.1 Middle East and Africa Darbepoetin Alfa Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Darbepoetin Alfa Sales by Country (2019-2030)
3.8.3 Middle East and Africa Darbepoetin Alfa Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Darbepoetin Alfa Sales by Type (2019-2030)
4.1.1 Global Darbepoetin Alfa Sales by Type (2019-2024)
4.1.2 Global Darbepoetin Alfa Sales by Type (2025-2030)
4.1.3 Global Darbepoetin Alfa Sales Market Share by Type (2019-2030)
4.2 Global Darbepoetin Alfa Revenue by Type (2019-2030)
4.2.1 Global Darbepoetin Alfa Revenue by Type (2019-2024)
4.2.2 Global Darbepoetin Alfa Revenue by Type (2025-2030)
4.2.3 Global Darbepoetin Alfa Revenue Market Share by Type (2019-2030)
4.3 Global Darbepoetin Alfa Price by Type (2019-2030)
5 Segment by Application
5.1 Global Darbepoetin Alfa Sales by Application (2019-2030)
5.1.1 Global Darbepoetin Alfa Sales by Application (2019-2024)
5.1.2 Global Darbepoetin Alfa Sales by Application (2025-2030)
5.1.3 Global Darbepoetin Alfa Sales Market Share by Application (2019-2030)
5.2 Global Darbepoetin Alfa Revenue by Application (2019-2030)
5.2.1 Global Darbepoetin Alfa Revenue by Application (2019-2024)
5.2.2 Global Darbepoetin Alfa Revenue by Application (2025-2030)
5.2.3 Global Darbepoetin Alfa Revenue Market Share by Application (2019-2030)
5.3 Global Darbepoetin Alfa Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Darbepoetin Alfa Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Darbepoetin Alfa Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Darbepoetin Alfa Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Darbepoetin Alfa Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Kyowa Hakko Kirin
6.3.1 Kyowa Hakko Kirin Corporation Information
6.3.2 Kyowa Hakko Kirin Description and Business Overview
6.3.3 Kyowa Hakko Kirin Darbepoetin Alfa Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Kyowa Hakko Kirin Darbepoetin Alfa Product Portfolio
6.3.5 Kyowa Hakko Kirin Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Darbepoetin Alfa Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Darbepoetin Alfa Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 3SBio
6.5.1 3SBio Corporation Information
6.5.2 3SBio Description and Business Overview
6.5.3 3SBio Darbepoetin Alfa Sales, Revenue and Gross Margin (2019-2024)
6.5.4 3SBio Darbepoetin Alfa Product Portfolio
6.5.5 3SBio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Darbepoetin Alfa Industry Chain Analysis
7.2 Darbepoetin Alfa Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Darbepoetin Alfa Production Mode & Process
7.4 Darbepoetin Alfa Sales and Marketing
7.4.1 Darbepoetin Alfa Sales Channels
7.4.2 Darbepoetin Alfa Distributors
7.5 Darbepoetin Alfa Customers
8 Darbepoetin Alfa Market Dynamics
8.1 Darbepoetin Alfa Industry Trends
8.2 Darbepoetin Alfa Market Drivers
8.3 Darbepoetin Alfa Market Challenges
8.4 Darbepoetin Alfa Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Darbepoetin Alfa Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Darbepoetin Alfa Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Darbepoetin Alfa Market Competitive Situation by Manufacturers in 2023
Table 4. Global Darbepoetin Alfa Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Darbepoetin Alfa Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Darbepoetin Alfa Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Darbepoetin Alfa Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Darbepoetin Alfa Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Darbepoetin Alfa, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Darbepoetin Alfa, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Darbepoetin Alfa, Product Type & Application
Table 12. Global Key Manufacturers of Darbepoetin Alfa, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Darbepoetin Alfa by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Darbepoetin Alfa as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Darbepoetin Alfa Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Darbepoetin Alfa Sales by Region (2019-2024) & (K Units)
Table 18. Global Darbepoetin Alfa Sales Market Share by Region (2019-2024)
Table 19. Global Darbepoetin Alfa Sales by Region (2025-2030) & (K Units)
Table 20. Global Darbepoetin Alfa Sales Market Share by Region (2025-2030)
Table 21. Global Darbepoetin Alfa Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Darbepoetin Alfa Revenue Market Share by Region (2019-2024)
Table 23. Global Darbepoetin Alfa Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Darbepoetin Alfa Revenue Market Share by Region (2025-2030)
Table 25. North America Darbepoetin Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Darbepoetin Alfa Sales by Country (2019-2024) & (K Units)
Table 27. North America Darbepoetin Alfa Sales by Country (2025-2030) & (K Units)
Table 28. North America Darbepoetin Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Darbepoetin Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Darbepoetin Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Darbepoetin Alfa Sales by Country (2019-2024) & (K Units)
Table 32. Europe Darbepoetin Alfa Sales by Country (2025-2030) & (K Units)
Table 33. Europe Darbepoetin Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Darbepoetin Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Darbepoetin Alfa Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Darbepoetin Alfa Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Darbepoetin Alfa Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Darbepoetin Alfa Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Darbepoetin Alfa Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Darbepoetin Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Darbepoetin Alfa Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Darbepoetin Alfa Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Darbepoetin Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Darbepoetin Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Darbepoetin Alfa Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Darbepoetin Alfa Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Darbepoetin Alfa Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Darbepoetin Alfa Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Darbepoetin Alfa Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Darbepoetin Alfa Sales (K Units) by Type (2019-2024)
Table 51. Global Darbepoetin Alfa Sales (K Units) by Type (2025-2030)
Table 52. Global Darbepoetin Alfa Sales Market Share by Type (2019-2024)
Table 53. Global Darbepoetin Alfa Sales Market Share by Type (2025-2030)
Table 54. Global Darbepoetin Alfa Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Darbepoetin Alfa Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Darbepoetin Alfa Revenue Market Share by Type (2019-2024)
Table 57. Global Darbepoetin Alfa Revenue Market Share by Type (2025-2030)
Table 58. Global Darbepoetin Alfa Price (USD/Unit) by Type (2019-2024)
Table 59. Global Darbepoetin Alfa Price (USD/Unit) by Type (2025-2030)
Table 60. Global Darbepoetin Alfa Sales (K Units) by Application (2019-2024)
Table 61. Global Darbepoetin Alfa Sales (K Units) by Application (2025-2030)
Table 62. Global Darbepoetin Alfa Sales Market Share by Application (2019-2024)
Table 63. Global Darbepoetin Alfa Sales Market Share by Application (2025-2030)
Table 64. Global Darbepoetin Alfa Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Darbepoetin Alfa Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Darbepoetin Alfa Revenue Market Share by Application (2019-2024)
Table 67. Global Darbepoetin Alfa Revenue Market Share by Application (2025-2030)
Table 68. Global Darbepoetin Alfa Price (USD/Unit) by Application (2019-2024)
Table 69. Global Darbepoetin Alfa Price (USD/Unit) by Application (2025-2030)
Table 70. Amgen Corporation Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Darbepoetin Alfa Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Amgen Darbepoetin Alfa Product
Table 74. Amgen Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Darbepoetin Alfa Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Johnson & Johnson Darbepoetin Alfa Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Kyowa Hakko Kirin Corporation Information
Table 81. Kyowa Hakko Kirin Description and Business Overview
Table 82. Kyowa Hakko Kirin Darbepoetin Alfa Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Kyowa Hakko Kirin Darbepoetin Alfa Product
Table 84. Kyowa Hakko Kirin Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Darbepoetin Alfa Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Novartis Darbepoetin Alfa Product
Table 89. Novartis Recent Developments/Updates
Table 90. 3SBio Corporation Information
Table 91. 3SBio Description and Business Overview
Table 92. 3SBio Darbepoetin Alfa Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. 3SBio Darbepoetin Alfa Product
Table 94. 3SBio Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Darbepoetin Alfa Distributors List
Table 98. Darbepoetin Alfa Customers List
Table 99. Darbepoetin Alfa Market Trends
Table 100. Darbepoetin Alfa Market Drivers
Table 101. Darbepoetin Alfa Market Challenges
Table 102. Darbepoetin Alfa Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Darbepoetin Alfa
Figure 2. Global Darbepoetin Alfa Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Darbepoetin Alfa Market Share by Type in 2023 & 2030
Figure 4. Epogen Product Picture
Figure 5. Procrit Product Picture
Figure 6. Aranesp Product Picture
Figure 7. Others Product Picture
Figure 8. Global Darbepoetin Alfa Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Darbepoetin Alfa Market Share by Application in 2023 & 2030
Figure 10. Patients with Chronic Kidney Disease
Figure 11. Patients with Cancer
Figure 12. Others
Figure 13. Global Darbepoetin Alfa Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Darbepoetin Alfa Market Size (2019-2030) & (US$ Million)
Figure 15. Global Darbepoetin Alfa Sales (2019-2030) & (K Units)
Figure 16. Global Darbepoetin Alfa Average Price (USD/Unit) & (2019-2030)
Figure 17. Darbepoetin Alfa Report Years Considered
Figure 18. Darbepoetin Alfa Sales Share by Manufacturers in 2023
Figure 19. Global Darbepoetin Alfa Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Darbepoetin Alfa Players: Market Share by Revenue in 2023
Figure 21. Darbepoetin Alfa Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Darbepoetin Alfa Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Darbepoetin Alfa Sales Market Share by Country (2019-2030)
Figure 24. North America Darbepoetin Alfa Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Darbepoetin Alfa Sales Market Share by Country (2019-2030)
Figure 28. Europe Darbepoetin Alfa Revenue Market Share by Country (2019-2030)
Figure 29. Germany Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Darbepoetin Alfa Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Darbepoetin Alfa Revenue Market Share by Region (2019-2030)
Figure 36. China Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Darbepoetin Alfa Sales Market Share by Country (2019-2030)
Figure 46. Latin America Darbepoetin Alfa Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Darbepoetin Alfa Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Darbepoetin Alfa Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Darbepoetin Alfa Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Darbepoetin Alfa by Type (2019-2030)
Figure 56. Global Revenue Market Share of Darbepoetin Alfa by Type (2019-2030)
Figure 57. Global Darbepoetin Alfa Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Darbepoetin Alfa by Application (2019-2030)
Figure 59. Global Revenue Market Share of Darbepoetin Alfa by Application (2019-2030)
Figure 60. Global Darbepoetin Alfa Price (USD/Unit) by Application (2019-2030)
Figure 61. Darbepoetin Alfa Value Chain
Figure 62. Darbepoetin Alfa Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
